Medtronic plc

MDT ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $36.36B $33.54B $32.15B $31.22B $31.90B $30.11B $28.91B $31.18B
Cardiovascular $11.83B $11.57B $11.63B $10.77B $10.47B $11.51B
Medical Surgical $8.42B $8.43B $9.14B $8.74B $8.35B $9.10B
Neuroscience $9.41B $8.96B $8.78B $8.19B $7.73B $8.18B
Diabetes $2.49B $2.26B $2.34B $2.41B $2.37B $2.39B
Cost of Revenue $12.72B $11.63B $11.22B $10.72B $10.15B $10.48B $9.42B $9.16B
Gross Profit $23.64B $21.91B $20.93B $20.50B $21.75B $19.63B $19.49B $22.02B
Gross Margin 65.0% 65.3% 65.1% 65.7% 68.2% 65.2% 67.4% 70.6%
Operating Expenses
Research & Development
SG&A Expense $11.78B $10.85B $10.74B $10.42B $10.29B $10.15B $10.11B $10.42B
Operating Income $6.47B $5.96B $5.14B $5.49B $5.75B $4.48B $4.79B $6.27B
Operating Margin 17.8% 17.8% 16.0% 17.6% 18.0% 14.9% 16.6% 20.1%
Interest Expense $719.0M $636.0M $553.0M $925.0M $1.09B $1.44B
Pretax Income $6.14B $5.63B $4.84B $5.36B $5.52B $3.90B $4.06B $5.20B
Income Tax Expense $1.30B $936.0M $1.13B $1.58B $456.0M $265.0M $-751.0M $547.0M
Net Income $4.80B $4.66B $3.68B $3.76B $5.04B $3.61B $4.79B $4.63B
Net Margin 13.2% 13.9% 11.4% 12.0% 15.8% 12.0% 16.6% 14.9%
EPS (Basic) $3.75 $3.63 $2.77 $2.83 $3.75 $2.68 $3.57 $3.44
EPS (Diluted) $3.73 $3.61 $2.76 $2.82 $3.73 $2.66 $3.54 $3.41
Shares Outstanding (Basic) 1.28B 1.29B 1.33B 1.33B 1.34B 1.34B 1.34B 1.35B
Shares Outstanding (Diluted) 1.29B 1.29B 1.33B 1.33B 1.35B 1.35B 1.35B 1.36B
Dividends Per Share $2.84 $2.80 $2.76 $2.72 $2.52 $2.32 $2.16 $2.00
← Newer Page 1 of 2 Older →